Important role for FcγRIIB on B lymphocytes for mucosal antigen-induced tolerance and Foxp3+ regulatory T cells

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4412-4422

  Sun, Jia Bin ^a,b   Xiang, Zou ^b   Smith, Kenneth G C ^c   Holmgren, Jan ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHOLERA TOXIN B SUBUNIT OVALBUMIN CONJUGATE; FC RECEPTOR IIB; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHOLERA TOXIN; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, IGG; T-LYMPHOCYTES, REGULATORY;

EID: 84885466885     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301324     Document Type: Article

References (37)

1. Weiner, H. L., A. P. da Cunha, F. Quintana, and H. Wu. 2011. Oral tolerance. Immunol. Rev. 241: 241-259.
2. Pabst, O., and A. M. Mowat. 2012. Oral tolerance to food protein. Mucosal Immunol. 5: 232-239.
3. Sun, J. B., J. Holmgren, and C. Czerkinsky. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91: 10795-10799.
4. Sun, J. B., C. Rask, T. Olsson, J. Holmgren, and C. Czerkinsky. 1996. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93: 7196-7201.
5. Sun, J. B., C. Czerkinsky, and J. Holmgren. 2010. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand. J. Immunol. 71: 1-11.
6. Arakawa, T., J. Yu, D. K. Chong, J. Hough, P. C. Engen, and W. H. Langridge. 1998. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 16: 934-938.
7. Bublin, M., E. Hoflehner, B. Wagner, C. Radauer, S. Wagner, K. Hufnagl, D. Allwardt, M. Kundi, O. Scheiner, U. Wiedermann, and H. Breiteneder. 2007. Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses. Vaccine 25: 8395-8404.
8. Donaldson, D. S., M. Apostolaki, H. K. Bone, C. M. Richards, and N. A. Williams. 2013. The Escherichia coli heat-labile enterotoxin B subunit protects from allergic airway disease development by inducing CD4+ regulatory T cells. Mucosal Immunol. 6: 535-546.
9. Sun, J. B., S. Raghavan, A. Sjöling, S. Lundin, and J. Holmgren. 2006. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp32CD252 CD4+ regulatory T cells. J. Immunol. 177: 7634-7644.
10. Sun, J. B., C. F. Flach, C. Czerkinsky, and J. Holmgren. 2008. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J. Immunol. 181: 8278-8287.
11. George-Chandy, A., K. Eriksson, M. Lebens, I. Nordström, E. Schön, and J. Holmgren. 2001. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigenpresenting cells. Infect. Immun. 69: 5716-5725.
12. Odumosu, O., D. Nicholas, K. Payne, and W. Langridge. 2011. Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. Vaccine 29: 8451-8458.
13. Mizoguchi, A., E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan. 1997. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 186: 1749-1756.
14. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
15. Bouaziz, J. D., K. Yanaba, and T. F. Tedder. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214.
16. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
17. Tian, J., D. Zekzer, L. Hanssen, Y. Lu, A. Olcott, and D. L. Kaufman. 2001. Lipopolysaccharide-Activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 1081-1089.
18. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
19. Hussain, S., and T. L. Delovitch. 2007. Intravenous transfusion of BCR-Activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J. Immunol. 179: 7225-7232.
20. Kalampokis, I., A. Yoshizaki, and T. F. Tedder. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 15(Suppl. 1): S1.
21. Gonnella, P. A., H. P. Waldner, and H. L. Weiner. 2001. B cell-deficient (mu MT) mice have alterations in the cytokine microenvironment of the gut-Associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance. J. Immunol. 166: 4456-4464.
22. Sun, J. B., C. Czerkinsky, and J. Holmgren. 2012. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis. J. Immunol. 188: 1686-1697.
23. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
24. Bolland, S., Y. S. Yim, K. Tus, E. K. Wakeland, and J. V. Ravetch. 2002. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(2/2) mice. J. Exp. Med. 195: 1167-1174.
25. Brownlie, R. J., K. E. Lawlor, H. A. Niederer, A. J. Cutler, Z. Xiang, M. R. Clatworthy, R. A. Floto, D. R. Greaves, P. A. Lyons, and K. G. C. Smith. 2008. Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J. Exp. Med. 205: 883-895.
26. Smith, K. G., and M. R. Clatworthy. 2010. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol. 10: 328-343.
27. Espéli, M., M. R. Clatworthy, S. Bökers, K. E. Lawlor, A. J. Cutler, F. Köntgen, P. A. Lyons, and K. G. Smith. 2012. Analysis of a wild mouse promoter variant reveals a novel role for FcgRIIb in the control of the germinal center and autoimmunity. J. Exp. Med. 209: 2307-2319.
28. van Montfoort, N., P. A. Hoen, S. M. Mangsbo, M. G. Camps, P. Boross, C. J. Melief, F. Ossendorp, and J. S. Verbeek. 2012. Fcg receptor IIb strongly regulates Fcg receptor-facilitated T cell activation by dendritic cells. J. Immunol. 189: 92-101.
29. Bruhns, P., S. Frémont, and M. Daëron. 2005. Regulation of allergy by Fc receptors. Curr. Opin. Immunol. 17: 662-669.
30. Samsom, J. N., L. A. van Berkel, J. M. van Helvoort, W. W. Unger, W. Jansen, T. Thepen, R. E. Mebius, S. S. Verbeek, and G. Kraal. 2005. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. J. Immunol. 174: 5279-5287.
31. Watanabe, T., M. Okano, H. Hattori, T. Yoshino, N. Ohno, N. Ohta, Y. Sugata, Y. Orita, T. Takai, and K. Nishizaki. 2004. Roles of FcgammaRIIB in nasal eosinophilia and IgE production in murine allergic rhinitis. Am. J. Respir. Crit. Care Med. 169: 105-112.
32. Gonnella, P. A., Y. H. Chen, H. Waldner, and H. L. Weiner. 2006. Induction of oral tolerization in CD86 deficient mice: a role for CD86 and B cells in the upregulation of TGF-beta. J. Autoimmun. 26: 73-81.
33. Montagnoli, C., S. Bozza, A. Bacci, R. Gaziano, P. Mosci, J. Morschhäuser, L. Pitzurra, M. Kopf, J. Cutler, and L. Romani. 2003. A role for antibodies in the generation of memory antifungal immunity. Eur. J. Immunol. 33: 1193-1204.
34. Woelbing, F., S. L. Kostka, K. Moelle, Y. Belkaid, C. Sunderkoetter, S. Verbeek, A. Waisman, A. P. Nigg, J. Knop, M. C. Udey, and E. von Stebut. 2006. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J. Exp. Med. 203: 177-188.
35. Moulin, V., F. Andris, K. Thielemans, C. Maliszewski, J. Urbain, and M. Moser. 2000. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192: 475-482.
36. Iruretagoyena, M. I., C. A. Riedel, E. D. Leiva, M. A. Gutiérrez, S. H. Jacobelli, and A. M. Kalergis. 2008. Activating and inhibitory Fcgamma receptors can differentially modulate T cell-mediated autoimmunity. Eur. J. Immunol. 38: 2241-2250.
37. Floto, R. A., M. R. Clatworthy, K. R. Heilbronn, D. R. Rosner, P. A. MacAry, A. Rankin, P. J. Lehner, W. H. Ouwehand, J. M. Allen, N. A. Watkins, and K. G. Smith. 2005. Loss of function of a lupus-Associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11: 1056-1058.